Skip to content
Forensic Analysis · Communications Equipment & Electronic Components · as of Nov 9, 2026

Microvision, Inc. (MVIS)

A forensic read on Microvision, Inc. built from its complete SEC filings — financial-health screens, earnings quality, red flags and a price-aware rating. Reproducible math, not opinion.

F · Poor — capital at risk
Forensic grade
Distress
Financial health
-31.2
Distress distance
3
Forensic signals
-182.1%
ROE
-74.3%
Revenue growth

This free snapshot doesn't read filing or proxy text, so the auditor-quality and governance checks that can lower a grade were not evaluated (auditor quality, say on pay, board independence, going concern). Those checks only ever lower a grade, so the full analysis can land below the grade above but never above it — treat it as the most favourable reading, not the settled one.

Microvision, Inc. earns an F (Poor — capital at risk) forensic quality grade, and its balance-sheet distress test reads -31.2, placing it in the Distress zone. 3 forensic signals were flagged in its latest SEC filings, led by accruals ratio (% of NOA).

What the filings flag

+43.4%
FY2024→FY2025
Accruals ratio (% of NOA). Net operating assets grew +43.4% relative to their own average in FY2025 — scaled by NOA itself, not by total assets, which is what the Forensic Screens card's own accrual row divides by. Accruals are building sharply — a large slice of profit sits in operating assets, not cash. An accrual is a claim that still has to be collected or written down, so the gap resolves in a later period whichever way it goes. A cash-flow measure on the same base disagrees: reported earnings ran behind operating cash by 104% of net operating assets, against an accruals ratio of 43.4%. The two are computed differently: the accruals ratio is the change in net operating assets over average net operating assets, while the cash-flow figure is net income less operating cash flow over that same average. Read them as two results, not one.Accruals ratio: the year-over-year change in net operating assets, relative to their own average.NOA (net operating assets): the money tied up in running the business, operating assets minus operating liabilities.
+22.2%/yr
FY2023–FY2025
Share-count dilution. Diluted share count changed +49% over the last 2 years to FY2025 (+22.2%/yr). The count is growing — 182.8M shares in FY2023, 273.1M in FY2025: more stock was issued than repurchased over this window, so aggregate results grew faster than their per-share equivalents. That's ~22.2% shaved off per-share growth every year — total profit has to grow that much just to keep earnings-per-share flat, and a stake held since FY2023 has been diluted ~33%.
58% of rev
FY2025
Stock-based comp load. Stock-based compensation ran 58% of revenue in FY2025 — about $0.00 per diluted share. No cash left the business to pay it, which is why operating cash flow adds it back. Net of repurchases the diluted count still rose about 22.2% a year across FY2023–FY2025 and that rate is not falling, so total profit has to grow by that much annually before any of it reaches a share. Stock compensation is one source of that issuance; acquisition consideration, equity raises, convertibles and other employee plans also net into the count, and these figures do not separate them.

Key fundamentals

Latest Revenue$1.2M
Revenue Growth YoY-74.3%
Revenue CAGR (2yr)-59.2%
Net Margin-7862.7%
Free Cash Flow-$59.4M
Return on Equity-182.1%
Debt / Equity0.35x

The forensic grade and screens above are free — no account needed. Want the AI investment read on top — the 0–100 rating, thesis, bull-vs-bear, red flags and the 12-month scenario, written from Microvision, Inc.'s actual 10-K/10-Q/8-K filings?

Generate the AI investment read →

No credit card · informational only, not investment advice · see the track record

← Browse all forensic stock analyses

Data from SEC EDGAR public filings · metrics as of Nov 9, 2026. Forensic signals flag probability, not certainty.

See a wrong number? Report an error with the filing it should match.